The DOI matches its Crossref record; 332 of the 332 references it cites were found in a registry or an index.
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
Open accessAbstract
The platinum drugs, cisplatin, carboplatin, and oxaliplatin, prevail in the treatment of cancer, but new platinum agents have been very slow to enter the clinic. Recently, however, there has been a surge of activity, based on a great deal of mechanistic information, aimed at developing nonclassical platinum complexes that operate via mechanisms of action distinct from those of the approved drugs. The use of nanodelivery devices has also grown, and many different strategies have been explored to incorporate platinum warheads into nanomedicine constructs. In this Review, we discuss these efforts to create the next generation of platinum anticancer drugs. The introduction provides the reader with a brief overview of the use, development, and mechanism of action of the approved platinum drugs to provide the context in which more recent research has flourished. We then describe approaches that explore nonclassical platinum(II) complexes with trans geometry or with a monofunctional coordination mode, polynuclear platinum(II) compounds, platinum(IV) prodrugs, dual-threat agents, and photoactivatable platinum(IV) complexes. Nanoparticles designed to deliver platinum(IV) complexes will also be discussed, including carbon nanotubes, carbon nanoparticles, gold nanoparticles, quantum dots, upconversion nanoparticles, and polymeric micelles. Additional nanoformulations, including supramolecular self-assembled structures, proteins, peptides, metal-organic frameworks, and coordination polymers, will then be described. Finally, the significant clinical progress made by nanoparticle formulations of platinum(II) agents will be reviewed. We anticipate that such a synthesis of disparate research efforts will not only help to generate new drug development ideas and strategies, but also will reflect our optimism that the next generation of approved platinum cancer drugs is about to arrive.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–332 of 332
Silk Fibroin-Derived Nanoparticles for Biomedical Applications
Mathur, A. B., & Gupta, V. (2010) · Nanomedicine · doi:10.2217/nnm.10.51 · Cited by 110
Baruah, H., Barry, C. G., & Bierbach, U. (2004) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026043387313 · Cited by 108
Platinum(IV)-chlorotoxin (CTX) conjugates for targeting cancer cells
Graf, N., Mokhtari, T. E., Papayannopoulos, I. A., & Lippard, S. J. (2012) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2012.02.012 · Cited by 107
Self-citationGRABOWSKI, P., MAASER, K., Schindler, I., Foss, H., STEIN, H., CARAYON, P., Gavish, M., RIECKEN, E., Zeitz, M., & SCHERUEBL, H. (2001) · Gastroenterology · doi:10.1016/s0016-5085(01)80171-2 · Cited by 105
Ait‐Oudhia, S., Mager, D. E., & Straubinger, R. M. (2014) · Pharmaceutics · doi:10.3390/pharmaceutics6010137 · Cited by 105
Peripheral-type benzodiazepine receptor density and in vitro tumorigenicity of glioma cell lines
Veenman, L., Levin, E., Weisinger, G., Leschiner, S., Spanier, I., Snyder, S. H., Weizman, A., & Gavish, M. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.05.011 · Cited by 105
Nováková, O., Kasparkova, J., Malina, J., Natile, G., & Brabec, V. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg863 · Cited by 105
Thermogelling Polymer–Platinum(IV) Conjugates for Long-Term Delivery of Cisplatin
Shen, W., Luan, J., Cao, L., Sun, J., Yu, L., & Ding, J. (2014) · Biomacromolecules · doi:10.1021/bm501220a · Cited by 104
Xiao, H., Noble, G. T., Stefanick, J. F., Qi, R., Kiziltepe, T., Jing, X., & Bilgiçer, B. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.10.020 · Cited by 104
Zhao, Y., Woods, J. A., Farrer, N. J., Robinson, K. S., Prachařová, J., Kašpárková, J., Nováková, O., Li, H., Salassa, L., Pizarro, A. M., et al. (2013) · Chemistry - A European Journal · doi:10.1002/chem.201300374 · Cited by 101
Ma, L., Ma, R., Wang, Y., Zhu, X. A., Zhang, J., Chan, H. C., Chen, X., Zhang, W., Chiu, S.-K., & Zhu, G. (2015) · Chemical Communications · doi:10.1039/c4cc10409a · Cited by 100
Mitaplatin Increases Sensitivity of Tumor Cells to Cisplatin by Inducing Mitochondrial Dysfunction
Xue, X., You, S., Zhang, Q., Wu, Y. F., Zou, G.-Z., Wang, P. C., Zhao, Y.-L., Xu, Y., Jia, L., Zhang, X., et al. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200571k · Cited by 99
Bose, R. N., Maurmann, L., Mishur, R. J., Yasui, L. S., Gupta, S., Grayburn, W. S., Hofstetter, H., & Salley, T. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803094105 · Cited by 98
Yuan, Y., Chen, Y., Tang, B. Z., & Liu, B. (2014) · Chemical Communications · doi:10.1039/c3cc49516g · Cited by 97
Optimization of cisplatin for the treatment of hormone dependent tumoral diseases
Gust, R., Beck, W., Jaouen, G., & Schönenberger, H. (2009) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2009.02.025 · Cited by 96
Nanoparticle Encapsulation of Mitaplatin and the Effect Thereof onIn VivoProperties
Johnstone, T. C., Kulak, N., Pridgen, E. M., Farokhzad, O. C., Langer, R., & Lippard, S. J. (2013) · ACS Nano · doi:10.1021/nn401905g · Cited by 96
Self-citationPolysilsesquioxane Nanoparticles for Targeted Platin‐Based Cancer Chemotherapy by Triggered Release
Rocca, J. D., Huxford, R. C., Comstock‐Duggan, E., & Lin, W. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201104510 · Cited by 96
Gold nanorods for platinum based prodrug delivery
Min, Y., Mao, C., Xu, D., Wang, J., & Liu, Y. (2010) · Chemical Communications · doi:10.1039/c0cc03108a · Cited by 95
Liu, P., Lu, Y., Gao, X., Liu, R., Zhang‐Negrerie, D., Shi, Y., Wang, Y., Wang, S., & Gao, Q. (2013) · Chemical Communications · doi:10.1039/c3cc38589b · Cited by 94
Biodegradable copolymers with identical cationic segments and their performance in siRNA delivery
Qi, R., Liu, S., Chen, J., Xiao, H., Yan, L., Huang, Y., & Jing, X. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.015 · Cited by 93
Yang, J. J., Liu, W., Sui, M., Tang, J., & Shen, Y. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.08.022 · Cited by 93
Sood, P., Thurmond, K. B., Jacob, J. E., Waller, L. K., Silva, G. O., Stewart, D. R., & Nowotnik, D. P. (2006) · Bioconjugate Chemistry · doi:10.1021/bc0600517 · Cited by 92
Wexselblatt, E., Yavin, E., & Gibson, D. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201300640 · Cited by 92
Cyclodextrin Capped Gold Nanoparticles as a Delivery Vehicle for a Prodrug of Cisplatin
Shi, Y., Goodisman, J., & Dabrowiak, J. C. (2013) · Inorganic Chemistry · doi:10.1021/ic400989v · Cited by 92
Kinetics and mechanism of uptake of platinum-based pharmaceuticals by the rat small intestine
Binks, S. P., & Dobrota, M. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90400-f · Cited by 91
Vitamin E TPGS prodrug micelles for hydrophilic drug delivery with neuroprotective effects
Mi, Y., Zhao, J., & Feng, S. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.08.038 · Cited by 91
Li, J., Yap, S. Q., Chin, C. F., Tian, Q., Yoong, S. L., Pastorin, G., & Ang, W. H. (2012) · Chemical Science · doi:10.1039/c2sc01086k · Cited by 91
Duong, H. T. T., Huynh, V. T., SOUZA, P. D., & Stenzel, M. H. (2010) · Biomacromolecules · doi:10.1021/bm100396s · Cited by 91
Anderson, H. D., Wagstaff, J. D., Crowther, D., Swindell, R., Lind, M., McGregor, J., Timms, M. S., Brown, D., & Palmer, P. A. (1988) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(88)90338-0 · Cited by 91
Billecke, C., Finniss, S., Tahash, L., Miller, C. G., Mikkelsen, T., Farrell, N. P., & Bögler, O. (2006) · Neuro-Oncology · doi:10.1215/15228517-2006-004 · Cited by 90
Muhsin, M., Graham, J., & Kirkpatrick, P. N. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1601 · Cited by 88
Westendorf, A. F., Woods, J. A., Korpis, K., Farrer, N. J., Salassa, L., Robinson, K. S., Appleyard, V. C. L., Murray, K. E., Grünert, R., Thompson, A. M., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0959 · Cited by 87
Baruah, H., Wright, M. W., & Bierbach, U. (2005) · Biochemistry · doi:10.1021/bi050021b · Cited by 85
Valproic acid resensitizes cisplatin‐resistant ovarian cancer cells
Lin, C., Lai, H., Lee, H., Lin, W., Chang, C., Chu, T., Lin, Y., Lee, K., & Yu, M. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00793.x · Cited by 85
Jackson, B. A., & Barton, J. K. (2000) · Biochemistry · doi:10.1021/bi9927033 · Cited by 83
Synergistic Cytotoxicity of Irinotecan and Cisplatin in Dual-Drug Targeted Polymeric Nanoparticles
Valencia, P. M., Pridgen, E. M., Perea, B., Gadde, S., Sweeney, C. J., Kantoff, P. W., Bander, N. H., Lippard, S. J., Langer, R., Karnik, R., et al. (2012) · Nanomedicine · doi:10.2217/nnm.12.134 · Cited by 83
Self-citationMcCormick, M. C., Keijzer, K., Polavarapu, A., Schultz, F. A., & Baik, M. (2014) · Journal of the American Chemical Society · doi:10.1021/ja5029765 · Cited by 82
Rocca, J. D., Werner, M. E., Kramer, S. A., Huxford‐Phillips, R. C., Sukumar, R., Cummings, N. D., Vivero-Escoto, J. L., Wang, A. Z., & Lin, W. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.07.004 · Cited by 81
Massaguer, A., González-Cantó, A., Escribano, E., Barrabés, S., Artigas, G., Moreno, V., & Marchán, V. (2014) · Dalton Transactions · doi:10.1039/c4dt02710h · Cited by 79
The Effects of Nanoparticle Drug Loading on the Pharmacokinetics of Anticancer Agents
Petschauer, J. S., Madden, A. J., Kirschbrown, W. P., Song, G. K., & Zamboni, W. C. (2015) · Nanomedicine · doi:10.2217/nnm.14.179 · Cited by 79
Antitumor platinum(IV) derivatives of oxaliplatin with axial valproato ligands
Novohradský, V., Zerzánková, L., Štěpánková, J., Vrána, O., Raveendran, R., Gibson, D., Kašpárková, J., & Brabec, V. (2014) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2014.07.004 · Cited by 79
Wei, M., Cohen, S. M., Silverman, A. P., & Lippard, S. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106374200 · Cited by 79
Self-citationParker, L. J., Italiano, L. C., Morton, C. J., Hancock, N. C., Ascher, D. B., Aitken, J. B., Harris, H. H., Campomanes, P., Röthlisberger, U., Luca, A. D., et al. (2011) · Chemistry - A European Journal · doi:10.1002/chem.201100586 · Cited by 79
Chiral Platinum(II) Metallointercalators with Potent in vitro Cytotoxic Activity
Fisher, D. M., Bednarski, P. J., Grünert, R., Turner, P., Fenton, R. R., & Aldrich-Wright, J. R. (2007) · ChemMedChem · doi:10.1002/cmdc.200600211 · Cited by 78
Chin, C. F., Yap, S. Q., Li, J., Pastorin, G., & Ang, W. H. (2014) · Chemical Science · doi:10.1039/c3sc53106f · Cited by 78
Xiao, H., Song, H., Zhang, Y., Qi, R., Wang, R., Xie, Z., Huang, Y., Li, Y., Wu, Y., & Jing, X. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.08.015 · Cited by 78
Kellinger, M. W., Park, G. Y., Chong, J. P. C., Lippard, S. J., & Wang, D. (2013) · Journal of the American Chemical Society · doi:10.1021/ja405475y · Cited by 78
Self-citationRecent Developments in Texaphyrin Chemistry and Drug Discovery
Preihs, C., Arambula, J. F., Magda, D. J., Jeong, H., Yoo, D., Cheon, J., Siddik, Z. H., & Sessler, J. L. (2013) · Inorganic Chemistry · doi:10.1021/ic400226g · Cited by 77
Synthesis of 17β-estradiol platinum(II) complexes: biological evaluation on breast cancer cell lines
Descôteaux, C., Provencher-Mandeville, J., Mathieu, I., Perron, V., Mandal, S. K., Asselin, É., & Bérubé, G. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.09.011 · Cited by 76
Peptide Targeting of Platinum Anti-Cancer Drugs
Ndinguri, M. W., Solipuram, R., Gambrell, R. P., Aggarwal, S., & Hammer, R. P. (2009) · Bioconjugate Chemistry · doi:10.1021/bc900065r · Cited by 76
Neumann, W., Crews, B. C., Marnett, L. J., & Hey‐Hawkins, E. (2014) · ChemMedChem · doi:10.1002/cmdc.201402074 · Cited by 76
In vivo biodistribution of platinum-based drugs encapsulated into multi-walled carbon nanotubes
Li, J., Pant, A., Chin, C. F., Ang, W. H., Ménard‐Moyon, C., Nayak, T. R., Gibson, D., Ramaprabhu, S., Pańczyk, T., Bianco, A., et al. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.01.004 · Cited by 75
Prachařová, J., Zerzánková, L., Štěpánková, J., Nováková, O., Farrer, N. J., Sadler, P. J., Brabec, V., & Kašpárková, J. (2012) · Chemical Research in Toxicology · doi:10.1021/tx300057y · Cited by 75
Zhao, Y., Farrer, N. J., Li, H., Butler, J. S., McQuitty, R. J., Habtemariam, A., Wang, F., & Sadler, P. J. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201307505 · Cited by 75
Zhu, G., Myint, M., Ang, W. H., Song, L., & Lippard, S. J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-3151 · Cited by 75
Self-citationRedox State-Dependent Interaction of HMGB1 and Cisplatin-Modified DNA
Park, S., & Lippard, S. J. (2011) · Biochemistry · doi:10.1021/bi2000214 · Cited by 74
Self-citationBaruah, H., Rector, C. L., Monnier, S. M., & Bierbach, U. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01107-3 · Cited by 74
A Carbohydrate-Linked Cisplatin Analogue Having Antitumor Activity
Chen, Y., Heeg, M. J., Braunschweiger, P. G., Xie, W., & Wang, P. G. (1999) · Angewandte Chemie International Edition · Cited by 73
Xue, Z., Lin, M., Zhu, J., Zhang, J., Li, Y., & Guo, Z. (2010) · Chemical Communications · doi:10.1039/b922222g · Cited by 73
New Perspectives on an Old Friend: Optimizing Carboplatin for the Treatment of Solid Tumors
Alberts, D. S., & Dorr, R. T. (1998) · The Oncologist · doi:10.1634/theoncologist.3-1-15 · Cited by 72
Solid-phase synthesis of oxaliplatin–TATpeptide bioconjugates
Abramkin, S. A., Valiahdi, S. M., Jakupec, M. A., et al. (2012) · Dalton Transactions · doi:10.1039/c2dt12024k · Cited by 69
Liposomes, a promising strategy for clinical application of platinum derivatives
Zalba, S., & Garrido, M. J. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.778240 · Cited by 69
Han, Y., Li, J., Zan, M., Luo, S., Ge, Z., & Liu, S. (2014) · Polymer Chemistry · doi:10.1039/c4py00064a · Cited by 68
Tuning the Activity of Mitochondria‐Penetrating Peptides for Delivery or Disruption
Horton, K. L., Pereira, M. P., Stewart, K. M., Fonseca, S. B., & Kelley, S. O. (2012) · ChemBioChem · doi:10.1002/cbic.201100415 · Cited by 68
The First Solid-Phase Synthesis of a Peptide-Tethered Platinum(II) Complex
Robillard, M. S., Valentijn, A. R. P. M., Meeuwenoord, N. J., MAREL, G. A. V. D., BOOM, J. H. V., & Reedijk, J. (2000) · Angewandte Chemie International Edition · Cited by 67
Yang, D., van Boom, S. S. G. E., Reedijk, J., BOOM, J. H. V., Farrell, N. P., & Wang, A. H. ‐. (1995) · Nature Structural Biology · doi:10.1038/nsb0795-577 · Cited by 66
Margiotta, N., Denora, N., Ostuni, R., Laquintana, V., Anderson, A. L., Johnson, S. W., Trapani, G., & Natile, G. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100429r · Cited by 66
Structural and mechanistic studies of polymerase η bypass of phenanthriplatin DNA damage
Gregory, M., Park, G. Y., Johnstone, T. C., Lee, Y., Yang, W., & Lippard, S. J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1405739111 · Cited by 65
Self-citationNear infrared activation of an anticancer Pt IV complex by Tm-doped upconversion nanoparticles
Ruggiero, E., Hernández‐Gil, J., Rivas, J. C. M., & Salassa, L. (2014) · Chemical Communications · doi:10.1039/c4cc07960d · Cited by 65
Iafisco, M., & Margiotta, N. (2012) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2012.06.004 · Cited by 64
Graf, N., Ang, W. H., Zhu, G., Myint, M., & Lippard, S. J. (2011) · ChemBioChem · doi:10.1002/cbic.201000724 · Cited by 64
Self-citationGaviglio, L., Groß, A., Metzler‐Nolte, N., & Ravera, M. (2012) · Metallomics · doi:10.1039/c2mt00171c · Cited by 62
Picazoplatin, an Azide-Containing Platinum(II) Derivative for Target Analysis by Click Chemistry
White, J. D., Osborn, M. F., Moghaddam, A. D., Guzmán, L. E., Haley, M. M., & DeRose, V. J. (2013) · Journal of the American Chemical Society · doi:10.1021/ja402453k · Cited by 60
Activation of Carboplatin by Carbonate
Pasqua, A. J. D., Goodisman, J., Kerwood, D. J., Toms, B. B., Dubowy, R. L., & Dabrowiak, J. C. (2005) · Chemical Research in Toxicology · doi:10.1021/tx050261s · Cited by 60
The Effect of Ligand Lipophilicity on the Nanoparticle Encapsulation of Pt(IV) Prodrugs
Johnstone, T. C., & Lippard, S. J. (2013) · Inorganic Chemistry · doi:10.1021/ic4010642 · Cited by 60
Self-citationHarris, A. L., Ryan, J. J., & Farrell, N. P. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.018762 · Cited by 58
Farrell, N. P., Povirk, L. F., Dange, Y., DeMasters, G. A., Gupta, M. S., Kohlhagen, G., Khan, Q. A., Pommier, Y. G., & Gewirtz, D. A. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.05.023 · Cited by 57
High-throughput synthesis and screening of platinum drug candidates
Ziegler, C. J., Silverman, A. P., & Lippard, S. J. (2000) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s007750000170 · Cited by 57
Self-citationMikata, Y., Shinohara, Y., Yoneda, K., Nakamura, Y., Brudziñska, I., Tanase, T., Kitayama, T., Takagi, R., Okamoto, T., Kinoshita, I., et al. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00623-0 · Cited by 56
Gagnon, V., St-Germain, M.-É., Descôteaux, C., Provencher-Mandeville, J., Parent, S., Mandal, S. K., Asselin, É., & Bérubé, G. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.09.015 · Cited by 55
Descôteaux, C., Leblanc, V., Bélanger, G., Parent, S., Asselin, É., & Bérubé, G. (2008) · Steroids · doi:10.1016/j.steroids.2008.04.009 · Cited by 54
Does cytotoxicity of metallointercalators correlate with cellular uptake or DNA affinity?
Davis, K. J., Carrall, J. A., Lai, B. C. H., Aldrich-Wright, J. R., Ralph, S. F., & Dillon, C. T. (2012) · Dalton Transactions · doi:10.1039/c2dt30217a · Cited by 54
Ferguson, H. M., Fréchet, J. M. J., & Szoka, F. C. (2013) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1209 · Cited by 52
Muzi, L., Ménard‐Moyon, C., Russier, J., Li, J., Chin, C. F., Ang, W. H., Pastorin, G., Risuleo, G., & Bianco, A. (2015) · Nanoscale · doi:10.1039/c5nr00220f · Cited by 51
Berger, I., Nazarov, A. A., Hartinger, C. G., Groessl, M., Valiahdi, S. M., Jakupec, M. A., & Keppler, B. K. (2007) · ChemMedChem · doi:10.1002/cmdc.200600279 · Cited by 51
Perron, V., Rabouin, D., Asselin, É., Parent, S., Gaudreault, R. C., & Bérubé, G. (2004) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2004.06.009 · Cited by 50
Kim, E., Rye, P. T., Essigmann, J. M., & Croy, R. G. (2008) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2008.10.013 · Cited by 49
Saha, P., Descôteaux, C., Brasseur, K., Fortin, S., Leblanc, V., Parent, S., Asselin, É., & Bérubé, G. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.12.017 · Cited by 48
Smyre, C. L., Saluta, G. R., Kute, T. E., Kucera, G. L., & Bierbach, U. (2011) · ACS Medicinal Chemistry Letters · doi:10.1021/ml2001888 · Cited by 47
Sasanelli, R., Boccarelli, A., Giordano, D., Laforgia, M., Arnesano, F., Natile, G., Cardellicchio, C., Capozzi, M. A. M., & Coluccia, M. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061435l · Cited by 47
Qiao, X., Ding, S., Liu, F., Kucera, G. L., & Bierbach, U. (2014) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-013-1086-1 · Cited by 46
Registries and Registration of Clinical Trials
Haug, C. J., Gøtzsche, P. C., & Schroeder, T. V. (2005) · New England Journal of Medicine · doi:10.1056/nejme058280 · Cited by 45
Mechanism of Two-Electron Oxidation of Deoxyguanosine 5‘-Monophosphate by a Platinum(IV) Complex
Choi, S., Cooley, R. B., Hakemian, A. S., Larrabee, Y. C., Bunt, R. C., Maupas, S. D., Muller, J. G., & Burrows, C. J. (2003) · Journal of the American Chemical Society · doi:10.1021/ja038334m · Cited by 44
Pérez, J. M., Montero, E. I., González, A. M., Álvarez-Valdés, A., Alonso, C., & Navarro‐Ranninger, C. (1999) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(99)00143-9 · Cited by 42
Liu, H., Li, Y., Lyu, Z., Wan, Y., Li, X., Chen, H., Chen, H., & Li, X. (2014) · Journal of Materials Chemistry B · doi:10.1039/c4tb01563k · Cited by 42
Overcoming tumor resistance to cisplatin through micelle-mediated combination chemotherapy
Zhou, D., Cong, Y., Qi, Y., He, S., Xiong, H., Wu, Y., Xie, Z., Chen, X., Jing, X., & Huang, Y. (2014) · Biomaterials Science · doi:10.1039/c4bm00305e · Cited by 41
Reithofer, M. R., Valiahdi, S. M., Galanski, M. S., Jakupec, M. A., Arion, V. B., & Keppler, B. K. (2008) · Chemistry & Biodiversity · doi:10.1002/cbdv.200890197 · Cited by 41
Stability of carboplatin and oxaliplatin in their infusion solutions is due to self-association
Pasqua, A. J. D., Kerwood, D. J., Shi, Y., et al. (2011) · Dalton Transactions · doi:10.1039/c0dt01758b · Cited by 40
Multifunctional Pt( iv ) pro-drug and its micellar platform: to kill two birds with one stone
Song, H., Xiao, H., Zhang, Y., Cai, H., Wang, R., Zheng, Y., Huang, Y., Li, Y., Xie, Z., Liu, T., et al. (2012) · Journal of Materials Chemistry B · doi:10.1039/c2tb00206j · Cited by 39
Suntharalingam, K., Wilson, J. J., Wei, L., & Lippard, S. J. (2014) · Metallomics · doi:10.1039/c3mt00364g · Cited by 38
Self-citationBinding Interaction of HMGB4 with Cisplatin-Modified DNA
Park, S., & Lippard, S. J. (2012) · Biochemistry · doi:10.1021/bi300649v · Cited by 38
Self-citationPhase I study of oral JM216 given twice daily
Beale, P. J., Raynaud, F. I., Hanwell, J., Berry, C., Moore, S., Odell, D. E., & Judson, I. R. (1998) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050797 · Cited by 37
Gandolfi, O., Blum, J., & Mandelbaum-Shavit, F. (1984) · Inorganica Chimica Acta · doi:10.1016/s0020-1693(00)81847-2 · Cited by 35
A cross-linked polymeric micellar delivery system for cisplatin(IV) complex
Song, H., Wang, R., Xiao, H., Cai, H., Zhang, W., Xie, Z., Huang, Y., Jing, X., & Liu, T. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.09.004 · Cited by 35
A Platinum(IV) Complex Oxidizes Guanine to 8-Oxo-Guanine in DNA and RNA
Choi, S., Delaney, S., Orbai, L., Padgett, E. J., & Hakemian, A. S. (2001) · Inorganic Chemistry · doi:10.1021/ic015549t · Cited by 35
Choi, S., Cooley, R. B., Voutchkova‐Kostal, A. M., Leung, C. H., Vastag, L., & Knowles, D. E. (2005) · Journal of the American Chemical Society · doi:10.1021/ja045194n · Cited by 34
The effects of 56MESS on mitochondrial and cytoskeletal proteins and the cell cycle in MDCK cells
Garbutcheon‐Singh, K. B., Myers, S. J., Harper, B. W. J., Ng, N. S., Dong, Q., Xie, C., & Aldrich-Wright, J. R. (2013) · Metallomics · doi:10.1039/c3mt00023k · Cited by 34
Du, R., Xiao, H., Guo, G., Jiang, B., Yan, X., Li, W., Yang, X., Zhang, Y. X., Li, Y., & Jing, X. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.10.015 · Cited by 33
Harris, A. L., Qu, Y., & Farrell, N. P. (2005) · Inorganic Chemistry · doi:10.1021/ic048356p · Cited by 32
Design and delivery of camplatin to overcome cisplatin drug resistance
Qi, R., Xiao, H., Wu, S., Li, Y., Zhang, Y., & Jing, X. (2014) · Journal of Materials Chemistry B · doi:10.1039/c4tb01146e · Cited by 31
Ogawa, M., Gale, G. R., & Keirn, S. S. (1975) · PubMed · Cited by 29
Barragán, F., Moreno, V., & Marchán, V. (2009) · Chemical Communications · doi:10.1039/b909698a · Cited by 29
Hope, J. M., Wilson, J. J., & Lippard, S. J. (2012) · Dalton Transactions · doi:10.1039/c2dt32462h · Cited by 29
Self-citationFortin, S., Brasseur, K., Morin, N., Asselin, É., & Bérubé, G. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.08.011 · Cited by 29
Eriksson, M., Hassan, S. B., Larsson, R. L., Linder, S., Ramqvist, T., Lövborg, H., Vikinge, T. P., Figgemeier, E., Müller, J., Stetefeld, J., et al. (2009) · PubMed · Cited by 29
Moghaddas, S., Majmudar, P., Marín, R., Dezvareh, H., Qi, C., Soans, E., & Bose, R. N. (2012) · Inorganica Chimica Acta · doi:10.1016/j.ica.2012.05.040 · Cited by 28
Mechanistic Insight into the Inhibition of Matrix Metalloproteinases by Platinum Substrates
Arnesano, F., Boccarelli, A., Cornacchia, D., Nushi, F., Sasanelli, R., Coluccia, M., & Natile, G. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900845t · Cited by 27
The new platinum-based anticancer agent LA-12 induces retinol binding protein 4 in vivo
Bouchal, P., Jarkovský, J., Hrazdilová, K., Dvořáková, M., Struhárová, I., Hernychová, L., Damborský, J., Sova, P., & Vojtěšek, B. (2011) · Proteome Science · doi:10.1186/1477-5956-9-68 · Cited by 27
Maldonado, C. R., Gomez-Blanco, N., Jauregui-Osoro, M., Brunton, V. G., Yate, L., & Rivas, J. C. M. (2013) · Chemical Communications · doi:10.1039/c3cc39104c · Cited by 26
DNA adducts of cisplatin, transplatin and platinum-intercalating drugs.
Leng, M., & Brabec, V. (1994) · PubMed · Cited by 26
Platinum (IV) coiled coil nanotubes selectively kill human glioblastoma cells
Thanasupawat, T., Bergen, H., Hombach‐Klonisch, S., Krcek, J. P., Ghavami, S., Bigio, M. R. D., Krawitz, S., Stelmack, G. L., Halayko, A. J., McDougall, M., et al. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.01.014 · Cited by 25
Antileukemic platinum(II)–catecholamine complexes
Gandolfi, O., & Blum, J. (1983) · Inorganica Chimica Acta · doi:10.1016/s0020-1693(00)91269-6 · Cited by 25
Synthesis of Novel gluco‐ and galacto‐Functionalized Platinum Complexes
Möker, J., & Thiem, J. (2009) · European Journal of Organic Chemistry · doi:10.1002/ejoc.200900691 · Cited by 24
Schobert, R., Biersack, B., Dietrich, A. M., Grotemeier, A., Müller, T. H., Kalinowski, B., Knauer, S., Voigt, W., & Paschke, R. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061379o · Cited by 23
Stepwise assembly of platinum–folic acid conjugates
Gabano, E., Ravera, M., Cassino, C., et al. (2007) · Inorganica Chimica Acta · doi:10.1016/j.ica.2007.09.020 · Cited by 21
Bernhardt, G., Biersack, B., Bollwein, S., Schobert, R., & Zoldáková, M. (2008) · Chemistry & Biodiversity · doi:10.1002/cbdv.200890152 · Cited by 18
Metalloimmunoassay. V. Steroid-Platinum(II)-o-catecholato complexes: A novel set of metallohaptens
Gandolfi, O., Cais, M., Dolcetti, G., Ghedini, M., & Modiano, A. (1981) · Inorganica Chimica Acta · doi:10.1016/s0020-1693(00)88557-6 · Cited by 18
Nanocapsules of Platinum Anticancer Drugs: Development Towards Therapeutic Use
Bryde, S., & de Kroon, A. I. P. M. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.112 · Cited by 14
Structure of matrix metalloproteinase-3 with a platinum-based inhibitor
Belviso, B. D., Caliandro, R., Siliqi, D., Calderone, V., Arnesano, F., & Natile, G. (2013) · Chemical Communications · doi:10.1039/c3cc41278d · Cited by 13
Lee, M., Simpson, J. E., Burns, A. J., Kupchinsky, S., Brooks, N. A., Hartley, J. A., & Kèlland, L. R. (1996) · UCL Discovery (University College London) · Cited by 12
Synthesis of Platinum Complexes from Sugar Derivatives
de Almeida, M. V., César, E. T., Fontes, A. P. S., & Felício, E. D. C. A. (2000) · Journal of Carbohydrate Chemistry · doi:10.1080/07328300008544081 · Cited by 10
Platinum complexes for multi-parametric assays using microarray systems
González‐González, M., Bartolomé-Casado, R., Matarraz, S., Rodríguez-Fernández, E., Manzano, J. L., Pérez‐Andrés, M., Órfão, A., Fuentes, M., & Criado, J. J. (2011) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2011.08.015 · Cited by 3
Cited by
Recent Strategies to Develop Innovative Photosensitizers for Enhanced Photodynamic Therapy
Pham, T. C., Nguyen, V.-N., Choi, Y., Lee, S., & Yoon, J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00381 · Cited by 1,813
Cisplatin: The first metal based anticancer drug
Ghosh, S. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.102925 · Cited by 1,751
The side effects of platinum-based chemotherapy drugs: a review for chemists
Oun, R., Moussa, Y. E., & Wheate, N. J. (2018) · Dalton Transactions · doi:10.1039/c8dt00838h · Cited by 1,737
Platinum-based drugs for cancer therapy and anti-tumor strategies
Zhang, C., Xu, C., Gao, X., & Yao, Q. (2022) · Theranostics · doi:10.7150/thno.69424 · Cited by 1,018
Zeng, L., Gupta, P., Chen, Y., Wang, E., Ji, L., Chao, H., & Chen, Z.-S. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00195a · Cited by 1,017
Metadata
- Authors
- Johnstone, T. C., Suntharalingam, K., & Lippard, S. J.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2016-02-11
- Volume
- 116
- Issue
- 5
- Pages
- 3436-3486
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W2282989227
- Cited by
- 2,485
- References
- 332
- FWCI
- 32.07
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.